People channel feed

Q&A with Ju­dith Ng-Cashin, CRO Novotech's chief med­ical of­fi­cer, on 2023 and be­yond

Last year

Biden taps Van­der­bilt’s Kim­ryn Rath­mell to suc­ceed Bertag­nol­li as the NI­H's can­cer chief

Last year
Pharma
FDA+

FDA's Janet Wood­cock to re­tire in ear­ly 2024

Last year
FDA+

Heard at #Jef­feries23: Al­ny­lam, Bi­cy­cle, In­tel­lia, Nous­com, Rakuten Med­ical ex­ecs fore­cast 2024

Last year
Pharma

Three months af­ter big re­or­ga­ni­za­tion, an­ti­body mak­er Atre­ca is back with an­oth­er round of lay­offs

Last year

Pfiz­er to cut 500 jobs at Sand­wich, UK site

Last year
Pharma

The­seus Phar­ma­ceu­ti­cals lays off most work­ers and seeks 's­trate­gic al­ter­na­tives' af­ter can­cer pipeline fail­ure

Last year
R&D

Or­bital Ther­a­peu­tics clos­es South San Fran­cis­co lab, elim­i­nat­ing some roles

Last year
Startups

Ther­mo Fish­er plans to lay off 97 em­ploy­ees, close fa­cil­i­ty in Al­aba­ma

Last year
Manufacturing

Re­genxbio looks to part­ner neu­rode­gen­er­a­tive gene ther­a­py work, lays off 15% of staff

Last year
Cell/Gene Tx

No­vavax’s trou­bles con­tin­ue as Covid vac­cine mak­er plans an­oth­er $300M+ in cost-cut­ting

Last year
Pharma

Sanofi CEO re­it­er­ates R&D bet is best long-term ap­proach, ad­dress­es probe on mar­ket ma­nip­u­la­tion al­le­ga­tions

Last year
Pharma

Lyell lays off 25% of staff and CMO leaves as com­pa­ny fore­shad­ows first clin­i­cal da­ta next year

Last year
R&D

The End­points Slack in­ter­view: Roivant CEO Matt Gline on play­ing mon­ey­ball in phar­ma, Vivek and pol­i­tics, and the $7B Roche deal

Last year

Pfiz­er to cut 200 jobs at Michi­gan plant that makes Covid prod­ucts

Last year
R&D
Pharma

Kro­nos Bio ax­es near­ly one-fifth of staff to pre­serve cash for two can­cer pro­grams

Last year
R&D

Seres Ther­a­peu­tics sheds about 160 jobs to fo­cus on com­mer­cial C. diff pill

Last year
R&D

Ro­bot­ic pill mak­er Rani paus­es pro­grams, cuts head­count to ex­tend cash run­way through 2025

Last year
R&D

Sang­amo lays off 160+ staffers, winds down fa­cil­i­ty, punts clin­i­cal pro­grams in dras­tic re­vamp

Last year
R&D

Gene ther­a­py biotech Lo­can­abio to shut­ter by year’s end

Last year
Startups
Cell/Gene Tx

JJ Bi­en­aimé is mov­ing out of the C-suite af­ter an 18-year run at Bio­Marin. And you like­ly know his suc­ces­sor

Last year

Q&A: PureTech CEO Daphne Zo­har talks biotech in­ter­ests on Capi­tol Hill

Last year
FDA+

Gala­pa­gos plans to hand over Jy­s­e­le­ca and 400 em­ploy­ees to Al­fasig­ma, re­duce work­force by 100

Last year
Deals
Pharma

Virid­i­an inks $185M fi­nanc­ing, hires three Ma­gen­ta ex­ec­u­tives as CEO Scott My­ers ex­its

Last year
First page Previous page 17181920212223 Next page Last page
A service from the Financial Times